Status:
COMPLETED
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Nigeria
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Clinton Health Access Initiative Inc.
Conditions:
Malaria
Febrile Illness
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
Highly subsidized first-line antimalarials (artemisinin combination therapy or ACT) are available over the counter in the private retail sector in most malaria-endemic countries. Overconsumption of AC...
Detailed Description
RATIONALE: The investigators hypothesize that decision-making in the retail sector is influenced primarily by price (or profit) supplemented by individual beliefs or preferences. Information from a d...
Eligibility Criteria
Inclusion
- All clients attending a participating outlet on the day selected for exit interviews will be eligible to be screened for inclusion into the interview sample.
- Participants with fever, or history of fever in the last 48 hours, or suspects they may have malaria
- Individual with malaria-like illness must be present at recruitment
- Older than one year of age
Exclusion
- Any individual with signs of severe illness requiring immediate referral
- Individuals who have taken an antimalarial in the last seven days, including for the current illness
- Patients \<18 years without a parent or legal guardian present
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
2205 Patients enrolled
Trial Details
Trial ID
NCT04428385
Start Date
March 15 2021
End Date
February 28 2023
Last Update
May 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinton Health Access Initiative
Lagos, Nigeria